GMC says it can’t force doctors to disclose payments from drug companiesBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i3806 (Published 07 July 2016) Cite this as: BMJ 2016;354:i3806
Read all the latest BMJ articles on Disclosure UK and view the linked infographics here.
- Ingrid Torjesen
The UK General Medical Council has admitted that it does not have the legal power to force doctors to disclose details of payments and benefits they receive from the pharmaceutical industry—either on the new database of the Association of the British Pharmaceutical Industry (ABPI) or the GMC’s own register.
Last week the ABPI published the Disclosure UK database (www.disclosureuk.org.uk) listing details of the fees and benefits in kind paid by the pharmaceutical industry to doctors, pharmacists, nurses, and healthcare organisations.1 However, only healthcare professionals and organisations consenting to being identified were named, and the remainder of the information was published in aggregate form.
The ABPI admitted that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial